BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells

Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis

(2013) Xiaoshen Dong et al.   Chinese Journal of Cancer Research

TWIST1 Is an ERK1/2 Effector That Promotes Invasion and Regulates MMP-1 Expression in Human Melanoma Cells

(2012) M. B. Weiss et al.   CANCER RESEARCH

Mixed lineage kinase 3 is required for matrix metalloproteinase expression and invasion in ovarian cancer cells

(2012) Yu Zhan et al.   EXPERIMENTAL CELL RESEARCH

GRB7 is required for triple-negative breast cancer cell invasion and survival

(2011) Orsi Giricz et al.   BREAST CANCER RESEARCH AND TREATMENT

Raf Kinase Inhibitor Protein RKIP Enhances Signaling by Glycogen Synthase Kinase-3β

(2011) Fahd Al-Mulla et al.   CANCER RESEARCH

Aberrant Expression of the p53-Inducible Antiproliferative Gene BTG2 in Hepatocellular Carcinoma is Associated with Overexpression of the Cell Cycle-Related Proteins

(2011) Zhimin Zhang et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Triple-negative breast cancers: an updated review on treatment options

(2011) K. B. Reddy   Current Oncology

MicroRNA miR-21 Regulates the Metastatic Behavior of B16 Melanoma Cells

(2011) Chuan He Yang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Loss of Hypermethylated in Cancer 1 (HIC1) in Breast Cancer Cells Contributes to Stress-induced Migration and Invasion through β-2 Adrenergic Receptor (ADRB2) Misregulation

(2011) Gaylor Boulay et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes

(2011) Anna Niwińska et al.   JOURNAL OF NEURO-ONCOLOGY

Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib

(2011) F Takahashi et al.   ONCOGENE

Molecular Stratification of Triple-Negative Breast Cancers

(2011) C. M. Perou   ONCOLOGIST

Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer

(2011) Mahavir B. Chougule et al.   PLoS One

Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer

(2011) Abderrahim El Guerrab et al.   PLoS One

Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray

(2010) Elin Möllerström et al.   BMC CANCER

Breast Cancer Dormancy Can Be Maintained by Small Numbers of Micrometastases

(2010) Lisa Willis et al.   CANCER RESEARCH

Characteristics of triple-negative breast cancer

(2010) Tim C. de Ruijter et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Survival among women with triple receptor-negative breast cancer and brain metastases

(2009) S. Dawood et al.   ANNALS OF ONCOLOGY

Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma

(2009) Min Liu et al.   CELL RESEARCH

Structural Basis for the Antiproliferative Activity of the Tob-hCaf1 Complex

(2009) Masataka Horiuchi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Age and Comorbidities Are Effect Modifiers of Gender Disparities in Renal Transplantation

(2009) D. L. Segev et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro

(2009) Lin Zhang et al.   MOLECULAR BIOLOGY REPORTS

p73α isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells

(2008) Emilie Horvilleur et al.   NUCLEIC ACIDS RESEARCH